ADIPOQ and heart failure: Furthermore, in patients with heart failure downregulation of adiponectin receptor is associated with decreased downstream signaling, such as inactivation of the PPAR-α/AMPK pathway, and downregulation of several target genes in skeletal muscles, resulting in functional resistance to adiponectin (39, 40).